Sameer Dhingra
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 5
-
- Antibiotic Use and Resistance 11
- Co-authors
- Mainul Haque (15 shared papers)Massimo Sartelli (5 shared papers)Salequl Islam (6 shared papers)Katia Iskandar (8 shared papers)Jaykaran Charan (12 shared papers)Tariqul Islam (3 shared papers)Milind Parle (11 shared papers)Mohamed Azmi Hassali (3 shared papers)
- Journals
- Expert Review of Anti-infective Therapy (3 papers)PLoS ONE (3 papers)Inflammopharmacology (3 papers)Biological Trace Element Research (2 papers)Pharmacological Reports (2 papers)
- Partner nations
- IndiaTrinidad and TobagoMalaysia
In The Last Decade
Sameer Dhingra
85 papers receiving 1.9k citations
Sameer Dhingra's Hit Papers
Peers
Comparison fields: 5 of 155
- Applied Microbiology and Biotechnology 422
- Molecular Medicine 268
- Biological Psychiatry 61
- Geriatrics and Gerontology 80
- Infectious Diseases 271
Countries citing papers authored by Sameer Dhingra
This map shows the geographic impact of Sameer Dhingra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Dhingra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Dhingra more than expected).
Fields of papers citing papers by Sameer Dhingra
This network shows the impact of papers produced by Sameer Dhingra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Dhingra. The network helps show where Sameer Dhingra may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameer Dhingra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture Hit paper breakdown → | 2021 | 267 |
| 2 | 2020 | 236 | |
| 3 | 2021 | 185 | |
| 4 | 2020 | 127 | |
| 5 | 2020 | 100 | |
| 6 | 2020 | 82 | |
| 7 | 2021 | 74 | |
| 8 | 2016 | 73 | |
| 9 | 2022 | 60 | |
| 10 | 2017 | 53 | |
| 11 | 2015 | 48 | |
| 12 | 2018 | 41 | |
| 13 | 2020 | 35 | |
| 14 | 2022 | 32 | |
| 15 | 2017 | 32 | |
| 16 | 2020 | 28 | |
| 17 | 2017 | 25 | |
| 18 | 2014 | 23 | |
| 19 | 2018 | 21 | |
| 20 | 2021 | 20 |
About Sameer Dhingra
Sameer Dhingra is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 98 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), Research on Leishmaniasis Studies (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Tryptophan and brain disorders (6 papers), COVID-19 Clinical Research Studies (5 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Vaccine Coverage and Hesitancy (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (422 citations), Molecular Medicine (268 citations), Biological Psychiatry (61 citations), Geriatrics and Gerontology (80 citations) and Infectious Diseases (271 citations). Sameer Dhingra has collaborated with scholars based in India, Trinidad and Tobago and Malaysia. Frequent co-authors include Mainul Haque, Massimo Sartelli, Salequl Islam, Katia Iskandar, Jaykaran Charan, Tariqul Islam, Milind Parle, Mohamed Azmi Hassali, Nor Azlina A. Rahman and Krishna Murti. Their work appears in journals such as Expert Review of Anti-infective Therapy, PLoS ONE, Inflammopharmacology, Biological Trace Element Research and Pharmacological Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.